Trials / Completed
CompletedNCT00875017
Comparing Absorption of Dietary Phosphorus When Administering FOSRENOL® or RENVELA® in Healthy Adult Volunteers
An Open-label, Phase I, One-dose, One-meal, Balance Study Comparing the Absorption of Dietary Phosphorus When Administering FOSRENOL® (Lanthanum Carbonate) or RENVELA® (Sevelamer Carbonate) in Healthy Adult Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 31 (actual)
- Sponsor
- Shire · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to compare the absorption of dietary phosphorus following a single dose with lanthanum carbonate (1000mg) and a single dose of sevelamer carbonate (2400mg).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lanthanum Carbonate | 1 x 1000mg tablet |
| DRUG | Sevelamer | 3 x 800mg tablets |
Timeline
- Start date
- 2009-04-20
- Primary completion
- 2009-06-16
- Completion
- 2009-06-16
- First posted
- 2009-04-03
- Last updated
- 2021-06-15
- Results posted
- 2010-07-02
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00875017. Inclusion in this directory is not an endorsement.